Arthur J. Ammann | Academic Influence

Arthur J. Ammann's AcademicInfluence.com Rankings

Arthur J. Ammann

Philosophy

#5689

World Rank

#8565

Historical Rank

#1455

USA Rank

Logic

#4676

World Rank

#5997

Historical Rank

#819

USA Rank

philosophy Degrees

Download Badge

Philosophy

Arthur J. Ammann's Degrees

Masters Medicine University of California, San Francisco
Bachelors Biology University of California, Berkeley

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is Arthur J. Ammann Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Arthur J. Ammann was an American pediatric immunologist and advocate known for his research on HIV transmission, discovering transmission and the risk of contaminated transfusions and blood products, and his role in the development of the first successful vaccine to prevent pneumococcal infection in 1977. He founded Global Strategies for HIV Prevention and was Clinical Professor of Pediatrics at the UCSF Medical Center.

(See a Problem?)

Arthur J. Ammann's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

NUCLEOSIDE-PHOSPHORYLASE DEFICIENCY IN A CHILD WITH SEVERELY DEFECTIVE T-CELL IMMUNITY AND NORMAL B-CELL IMMUNITY (1975) (756)
SELECTIVE IgA DEFICIENCY: PRESENTATION OF 30 CASES AND A REVIEW OF THE LITERATURE (1971) (506)
Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml. (2001) (389)
Polyvalent pneumococcal-polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy. (1977) (365)
ACQUIRED IMMUNODEFICIENCY IN AN INFANT: POSSIBLE TRANSMISSION BY MEANS OF BLOOD PRODUCTS (1983) (305)
B-cell immunodeficiency in acquired immune deficiency syndrome. (1984) (274)
Thymosin activity in patients with cellular immunodeficiency. (1975) (257)
Immunologic responses in malnourished children. (1975) (250)
Maternal HIV-1 viral load and vertical transmission of infection: The Ariel Project for the prevention of HIV transmission from mother to infant (1997) (209)
Pneumococcal polysaccharide immunization in infants and children. (1978) (199)
COMPLICATIONS OF CO-TRIMOXAZOLE IN TREATMENT OF AIDS-ASSOCIATED PNEUMOCYSTIS CARINII PNEUMONIA IN HOMOSEXUAL MEN (1983) (188)
Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency. (1978) (177)
Acquired immune dysfunction in homosexual men: immunologic profiles. (1983) (170)
Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside phosphorylase. (1976) (151)
MULTIPLE BIOTIN-DEPENDENT CARBOXYLASE DEFICIENCIES ASSOCIATED WITH DEFECTS IN T-CELL AND B-CELL IMMUNITY (1979) (150)
Use of intravenous gamma-globulin in antibody immunodeficiency: results of a multicenter controlled trial. (1982) (134)
Immunoglobulin E deficiency in ataxia-telangiectasia. (1969) (127)
Duration of ruptured membranes and vertical transmission of HIV-1: a meta-analysis from 15 prospective cohort studies (2001) (125)
Maternal transmission of acquired immune deficiency syndrome. (1984) (117)
The DiGeorge syndrome and the fetal alcohol syndrome. (1982) (110)
Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases. (1984) (109)
The Antibody Responses to Pneumococcal Capsular Polysaccharides in Aged Individuals 1 (1980) (109)
Acquired immune deficiency syndrome in childhood. (1985) (102)
The involvement of human tumor necrosis factors-alpha and -beta in the mixed lymphocyte reaction. (1988) (97)
PEDIATRIC ACQUIRED IMMUNODEFICIENCY SYNDROME (1984) (89)
Production of Lymphotoxin and Tumor Necrosis Factor by Human Neonatal Mononuclear Cells (1988) (89)
GROWTH RETARDATION IN SICKLE-CELL DISEASE TREATED BY NUTRITIONAL SUPPORT (1985) (87)
Association between maternal and infant class I and II HLA alleles and of their concordance with the risk of perinatal HIV type 1 transmission. (2002) (87)
Frequent Detection of Escape from Cytotoxic T-Lymphocyte Recognition in Perinatal Human Immunodeficiency Virus (HIV) Type 1 Transmission: the Ariel Project for the Prevention of Transmission of HIV from Mother to Infant (1999) (86)
Combined immunodeficiency presenting as the Letterer-Siwe syndrome. (1974) (79)
Immune Globulin Levels in Colostrum and Breast Milk, and Serum From Fomula- and Breast-Fed Newborns. (1966) (76)
Selective IgA deficiency and autoimmunity. (1970) (74)
The effects of human immunodeficiency virus recombinant envelope glycoprotein on immune cell functions in vitro. (1987) (74)
Elevated IgA in carcinoma of the nasopharynx (1975) (73)
Spectrum of Sjögren syndrome in children. (1981) (71)
Thymus transplantation. Permanent reconstitution of cellular immunity in a patient with sex-linked combined immunodeficiency. (1973) (69)
In vivo induction of bone by recombinant human transforming growth factor β1 (1991) (68)
Clinical and immunologic spectrum of the DiGeorge syndrome. (1981) (67)
The syndrome of cellular immunodeficiency with immunoglobulins. (1974) (66)
Determination of antibody to pneumococcal polysaccharides with chromic chloride-treated human red blood cells and indirect hemagglutination. (1972) (65)
Prevention of the graft-versus-host reaction in newborn mice by antibodies to tumor necrosis factor-alpha. (1989) (64)
Accelerated healing of ulcer wounds in the rabbit ear by recombinant human transforming growth factor-beta 1. (1990) (63)
T-lymphocyte subsets in lymph nodes from homosexual men. (1983) (60)
Recombinant human transforming growth factor-beta 1 (rhTGF-beta 1) enhances healing and strength of granulation skin wounds. (1990) (59)
Thymic transplantation in a case of chronic mucocutaneous candidiasis. (1971) (57)
Evaluation of T lymphocyte effector function in immunodeficiency diseases: abnormality in mitogen-stimulated interferon in patients with selective IgA deficiency. (1974) (57)
Low-Cost HIV-1 Diagnosis and Quantification in Dried Blood Spots by Real Time PCR (2009) (57)
Cytomegalovirus infection and abnormal T-lymphocyte subset ratios in homosexual men. (1985) (56)
Antibody-mediated immunodeficiency in short-limbed dwarfism. (1974) (56)
Thymosin treatment of children with primary immunodeficiency disease. (1978) (55)
RESPONSE TO PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN PATIENTS WITH UNTREATED HODGKIN'S DISEASE Children's Cancer Study Group Report (1980) (54)
Immunoglobulin G and M antibodies to pneumococcal polysaccharides detected by enzyme-linked immunosorbent assay (1980) (54)
Beh?et syndrome (1985) (50)
Autoimmune phenomena in ataxia telangiectasia. (1971) (46)
Suppression of immune cell function in vitro by recombinant human transforming growth factor-beta. (1988) (46)
ACTIVATION OF T‐CELL ROSETTES IN IMMUNODEFICIENT PATIENTS BY THYMOSIN (1975) (44)
IgG and IgM Pneumococcal Polysaccharide Antibody Responses in Infants (1984) (43)
Influence of HLA Alleles on the Rate of Progression of Vertically Transmitted HIV Infection in Children: Association of Several HLA-DR13 Alleles with Long-Term Survivorship and the Potential Association of HLA-A2301 with Rapid Progression to AIDS (1997) (43)
ALTERED DISTRIBUTION OF B AND T LYMPHOCYTES IN LYMPH-NODES FROM HOMOSEXUAL MEN WITH KAPOSI'S SARCOMA (1983) (42)
Significance of a positive antinuclear antibody test in a pediatric population. (1983) (41)
Immune Response to Acute Otitis Media in Children I. Serotypes Isolated and Serum and Middle Ear Fluid Antibody in Pneumococcal Otitis Media (1974) (41)
Long-term follow-up and booster immunization with polyvalent pneumococcal polysaccharide in patients with sickle cell anemia. (1984) (40)
Thymosin therapy in the DiGeorge syndrome. (1980) (39)
Transforming Growth Factor‐β Effect on Soft Tissue Repair (1990) (39)
Elevated cord macroglobulins in the diagnosis of intrauterine infections. (1966) (37)
Immunization of immunosuppressed patients with pneumococcal polysaccharide vaccine. (1981) (37)
Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assay (1981) (37)
Familial selective IgA deficiency. (1972) (34)
Unique antibody to basement membrane in patients with selective IgA deficiency and coeliac disease. (1971) (34)
Immunologic abnormalities in patients with hemophilia A. (1983) (34)
A study of allergy in patients with malignant lymphoma and chronic lymphocytic leukemia (1971) (33)
The acquired immunodeficiency syndrome in infants and children. (1985) (33)
Successful bone marrow transplantation in a patient with humoral and cellular immunity deficiency. (1970) (33)
IN VITRO AND IN VIVO ENHANCEMENT OF MIXED LYMPHOCYTE CULTURE REACTIVITY BY THYMOSIN IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASE (1979) (32)
A descriptive survey of pediatric human immunodeficiency virus-infected long-term survivors. (1997) (32)
Quantitation of B cells in peripheral blood by polyacrylamide beads coated with anti-human chain antibody. (1977) (32)
Tumor Necrosis Factors Alpha and Beta (1988) (31)
Human recombinant transforming growth factor-beta 1 modulation of biochemical and cellular events in healing of ulcer wounds. (1992) (31)
Immunosuppression following radiation therapy for carcinoma of the nasopharynx. (1975) (30)
An intraosseous device for studies of bone-healing. The effect of transforming growth-factor beta. (1992) (29)
Persistent Clq deficiency in a patient with a systemic lupus erythematosus-like syndrome. (1975) (29)
Maternal-fetal transfer of pneumococcal capsular polysaccharide antibodies. (1985) (29)
Preventing Mother-to-Child HIV Transmission in a Developing Country: The Dominican Republic Experience (2003) (29)
Influence of HLA alleles on the rate of progression of vertically transmitted HIV infection in children: association of several HLA-DR13 alleles with long-term survivorship and the potential association of HLA-A*2301 with rapid progression to AIDS. Long-Term Survivor Study. (1997) (28)
Lymphocyte abnormalities in infants born to drug-abusing mothers. (1987) (28)
Ocular microbial flora in immunodeficient patients. (1980) (28)
Long-term plasma infusions in a patient with ataxia-telangiectasia and deficient IGA and IGE. (1969) (27)
Endocrinological studies in ataxiatelangiectasia and other immunological deficiency diseases. (1970) (27)
Orotic aciduria in two unrelated patients with inherited deficiencies of purine nucleoside phosphorylase. (1977) (26)
Immunoregulation in aged humans. (1980) (25)
Chronic active Epstein-Barr virus infections in two immunodeficient patients. (1983) (25)
Selective absence of IgA. Autoimmune phenomena and autoimmune disease. (1972) (24)
Introduction to the Second Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants. (2000) (24)
Patients with abnormal proportions of T-lymphocyte subsets have reduced in vitro cellular immunity. (1983) (24)
Characterization of mutant subunits of human purine nucleoside phosphorylase. (1978) (23)
Is there an acquired immune deficiency syndrome in infants and children? (1983) (23)
Cartilage-hair hypoplasia: Effect of thymus transplants (1972) (23)
Anti-antiserum antibody as a cause of double precipitin rings in immunoglobulin quantitation and its relation to milk precipitins. (1971) (22)
THYMUS TRANSPLANTATION IN PATIENTS WITH THYMIC HYPOPLASIA AND ABNORMAL IMMUNOGLOBULIN SYNTHESIS (1975) (22)
In vivo induction of bone by recombinant human transforming growth factor beta 1. (1991) (22)
Cellular immunodeficiency associated with nucleoside phosphorylase deficiency. Immunologic and biochemical studies. (1977) (22)
T-CeII Reconstitution by Thymus Transplantation and Transfer Factor in Severe Combined lmmunodeficiency (1975) (22)
Is the “3 by 5” Initiative the Best Approach to Tackling the HIV Pandemic? (2004) (22)
Immunotherapy and immunopathologic studies in a patient with nucleoside phosphorylase deficiency. (1978) (22)
Diseases of cellular immunity. (1972) (22)
Cellular immune defect in selective IgA deficiency using a microculture method for PHA stimulation and limiting dilution. (1980) (21)
Antiretroviral therapy and medical management of the human immunodeficiency virus-infected child (1994) (21)
The prevalence of autoantibodies in T-cell, B-cell, and phagocytic immunodeficiency disorders. (1979) (21)
Phase I study of continuous-infusion soluble CD4 as a single agent and in combination with oral dideoxyinosine therapy in children with symptomatic human immunodeficiency virus infection. (1992) (21)
Strategies for prevention of perinatal transmission of HIV infection. Siena Consensus Workshop II. (1995) (20)
Pneumococcal vaccine in sickle cell disease: IgG and IgM antibody response. (1981) (20)
Purine salvage pathway enzyme activities in human T-, B-, and null lymphocyte populations. (1982) (19)
Combined immunodeficiency manifested by Letterer-Siwe syndrome. (1972) (19)
Human immunodeficiency virus infection/AIDS in children: the next decade. (1994) (19)
ASPERGILLUS PNEUMONIA IN CHRONIC GRANULOMATOUS DISEASE: RECURRENCE AND LONG‐TERM OUTCOME (1982) (19)
Immunological aberrations in purine nucleoside phosphorylase deficiencies. (1978) (18)
Haploidentical bone marrow transplantation for severe combined immunodeficiency disease using soybean agglutinin-negative, t-depleted marrow cells (1985) (17)
Transfer factor: therapy in patients with deficient cell-mediated immunity and deficient antibody-mediated immunity. (1974) (16)
Editorial: Thymic cells and humoral factors as therapeutic agents. (1976) (16)
Toxic epidermal necrolysis. (1972) (16)
Summary of the workshop on passive immunotherapy in the prevention and treatment of HIV infection. The Passive Antibody Workshop Participants. (1995) (16)
Effect of Antibody Concentration on Opsonic Requirements for Phagocytosis in Vitro of Streptococcus pneumoniae Types 7 and 19 (1983) (16)
Governments as facilitators or obstacles in the HIV epidemic (2002) (16)
Recurrent sinopulmonary infections, mental retardation, and combined IgA and IgE deficiency. (1970) (16)
Workshop Summary: Workshop on Perinatally Acquired Human Immunodeficiency Virus Infection in Long-Term Surviving Children: A Collaborative Study of Factors Contributing to Slow Disease Progression (1996) (15)
Preventing HIV (2003) (14)
Evaluation of infants and children with recurrent infection. (1975) (14)
Antibody-dependent lymphocyte killer function in human immunodeficiency diseases. (1975) (14)
Increased serum opsonic activity and antibody concentration in patients with sickle cell disease after pneumococcal polysaccharide immunization. (1983) (14)
Effect of thymosin on cellular immunity in old age (1981) (13)
Effect of growth hormone therapy on immune function. (1987) (13)
Virilizing ovarian tumor in a 2 1/2-year-old girl. (1967) (13)
Immunity toAspergillus in patients with chronic granulomatous disease (1977) (12)
T cell and T-B cell immunodeficiency disorders. (1977) (12)
IMMUNODEFICIENCY IN FAMILIAL ERYTHROPHAGOCYTIC LYMPHOHISTIOCYTOSIS (1978) (12)
Immunosuppression and reconstitution with thymosin after radiation therapy. (1978) (12)
Clinical and laboratory findings in childhood mixed connective tissue disease: presence of antibody to ribonucleoprotein containing the small nuclear ribonucleic acid U1. (1983) (12)
Deoxycytidine therapy in two patients with adenosine deaminase deficiency and severe immunodeficiency disease. (1985) (11)
Pseudolymphoma in two immunodeficient children. (1979) (11)
Effect of thymosin and irradiation on immune modulation in head and neck and esophageal cancer patients. (1978) (11)
Laboratory investigation of pediatric acquired immunodeficiency syndrome. (1986) (11)
Antibodies to AIDS-associated retrovirus distinguish between pediatric primary and acquired immunodeficiency diseases. (1985) (11)
Letter: T-cell rosettes in thyrotoxic Grave's disease. (1973) (11)
Incorporation of purine nucleosides in cultured fibroblasts from a patient with purine nucleoside phosphorylase deficiency and associated T‐cell immunodeficiency (1977) (10)
Tumor necrosis factors alpha and beta in acquired immunodeficiency syndrome (AIDS) and aids-related complex (1987) (10)
FETAL THYMUS GLANDS OBTAINED FROM PROSTAGLANDIN‐INDUCED ABORTIONS: CELLULAR IMMUNE FUNCTION IN VITRO AND EVIDENCE OF IN VIVO THYMOCYTE ACTIVITY FOLLOWING TRANSPLANTATION (1974) (10)
Differential specificity of lymphocytotoxins from patients with systemic lupus erythematosus and inflammatory bowel disease. (1976) (9)
Serum IgA in the diagnosis of nasopharyngeal and paranasal sinus carcinoma. (1975) (9)
Effects of formycin B on human lymphocyte Deoxyribonucleic acid synthesis. Optimization of cell culture conditions. (1981) (8)
Posttransfusion syndrome. Rash, eosinophilia, and thrombocytopenia following intrauterine and exchange transfusions. (1982) (8)
T-cell reconstitution by thymus transplantation and transfer factor in severe combined immunodeficiency. (1975) (8)
Delivering integrated care after sexual violence in the Democratic Republic of the Congo (2019) (8)
The Role of Trained Birth Attendants in Delivering PMTCT Services (2015) (7)
Immunodeficiency syndromes associated with inherited metabolic disorders. (1981) (7)
Immunity to Aspergillus in patients with chronic granulomatous disease. (1977) (7)
Recognition of Acquired Immune Deficiency Syndrome (AIDS) in Children (1985) (7)
Optimal versus suboptimal treatment for HIV-infected pregnant women and HIV-exposed infants in clinical research studies. (2009) (7)
Interleukin 2 responsive lymphocytes in patients with adenosine deaminase deficiency. (1989) (7)
Transforming growth factor-beta. Effect on soft tissue repair. (1990) (7)
Treatment of severe combined immunodeficiency by a small number of pretreated nonmatched marrow cells. (1973) (6)
New insight into the causes of immunodeficiency disorders. (1984) (6)
Transient HIV infection in infants. (1996) (6)
The Clinical Evaluation of Cytokines and Immunomodulators in HIV Infection (1993) (6)
Tumor necrosis factor-alpha-associated uterine endothelial injury in vivo. Influence of dietary fat. (1989) (6)
Behçet syndrome. (2020) (6)
Immunology of Streptococcus pneumoniae (1981) (6)
HIV in China: an opportunity to halt an emerging epidemic. (2000) (6)
Handbook of Pediatric HIV Care, 2nd Edition (2006) (5)
Changes in purine nucleoside phosphorylase activity during thymosin-induced human null cell differentiation. (1983) (5)
Progressive lymphoid system deterioration: a new familial lymphopenic immunological deficiency disease. (1970) (5)
Impaired mononuclear-cell proliferation in patients with the acquired immune deficiency syndrome results from abnormalities of both T lymphocytes and adherent mononuclear cells (1985) (5)
Dipyridamole and intravenous deoxycytidine therapy in a patient with adenosine deaminase deficiency. (1983) (5)
Graft versus host disease: Pathogenesis, recognition, prevention and treatment (1978) (5)
AIDS TRANSMISSION VIA TRANSFUSION THERAPY (1984) (5)
Healthy IgE-deficient person. (1970) (5)
The immunology of AIDS. (1989) (4)
Purine nucleotide imbalance in immunodeficiency disorders. (1985) (4)
Hypothesis: absence of graft-versus-host disease in AIDS is a consequence of HIV-1 infection of CD4+ T cells. (1993) (4)
Current status of pneumococcal polysaccharide immunization in patients with sickle cell disease or impaired splenic function. (1982) (4)
Helper cell function of human fetal thymocytes. (1981) (4)
Prevention and treatment of HIV infection in infants and children (2000) (4)
Acquired immune dysfunction in homosexual men. (1982) (4)
Zidovudine for mother, fetus, and child (1994) (4)
Unrestricted routine prenatal HIV testing: the standard of care. (1995) (4)
Immunologic competence in adults following thymic irradiation in infancy. (1977) (3)
Ataxia-telangiectasia and Autoimmunity (1970) (3)
Tubular reticular structures in peripheral mononuclear cells of males with chronic granulomatous disease and female carriers (1975) (3)
Intravenous deoxycytidine therapy in a patient with adenosine deaminase deficiency. (1984) (3)
Response of agranulocytosis to prolonged antithymocyte globulin therapy. (1983) (3)
Milk precipitins in selective IgA deficiency. (1979) (3)
CUTANEOUS SIGNALS OF HOST‐DEFENSE FAILURE (1977) (3)
Maternal-fetal graft vs host reaction (1975) (3)
Leiner's disease and C5 deficiency. (1972) (3)
Mother–infant HIV transmission: Making the most of what we know (1996) (3)
Indications for pneumococcal vaccine in patients with impaired splenic function. (1978) (2)
Completing the Public Health HIV/AIDS Alphabet (2005) (2)
967 REJECTION OF BONE MARROW TRANSPLANT (BMT) AND RESISTANCE OF ALLOANTIGEN REACTIVE CELLS TO IN VIVO DEOXYADENOSINE (DAD) IN A PATIENT WITH ADENOSINE DEAMINASE (ADA) DEFICIENCY (1985) (2)
Human Immunodeficiency Virus: An Epidemic without Precedent (2000) (2)
Big-Picture Thinking (2020) (2)
Priorities in psychosocial research in pediatric human immunodeficiency virus infection. (1994) (2)
Etiology of AIDS. (1984) (2)
Pneumococcal polysaccharide immunization. (1984) (2)
The ongoing HIV epidemic (2002) (2)
NORMOTRIGLYCERIDEMIC ABETALIPOPROTEINEMIA - CLINICAL AND BIOCHEMICAL FEATURES OF A NEW SYNDROME (1977) (2)
US clinical-research system in need of review (2013) (2)
Were the interests of the vulnerable truly served? The predictable failure of HIVIG. (2012) (1)
Biologic and immunomodulating factors in the treatment of pediatric acquired immunodeficiency syndrome. (1990) (1)
Alpha-fetoprotein levels in immunodeficiency. (1986) (1)
Author's Reply (1985) (1)
AIDS decision threatens drugs trials (1999) (1)
A 13-year-old HIV-infected girl with thrombocytopenia : paediatric case discussion, July 2006 : case study (2006) (1)
Biologic Effects of Tumor Necrosis Factors Alpha and Beta (1988) (1)
Inequalities in clinical research (2016) (1)
Lethal Decisions: The Unnecessary Deaths of Women and Children from HIV/AIDS (2017) (1)
Impaired monocyte-to-macrophage maturation in patients with lymphadenopathy syndrome (1986) (1)
TUBULAR RETICULAR STRUCTURES IN PERIPHERAL MONONUCLEAR CELLS OF MALES WITH CHRONIC GRANULOMATOUS DISEASE, THEIR MOTHERS, AND SISTER CARRIERS (1974) (1)
Determination of Antibody to Pneumococcal Polysaccharides with Chromic Chloride-Treated Human Red Blood Cells and Indirect Hemagglutination (1972) (1)
Further characterisation of a spontaneously occurring antibasement membrane antibody. (1978) (1)
MISMATCHED BONE MARROW TRANSPLANTATION (BMT) USING SOYBEAN AGGLUTININ (SBA) NEGATIVE MARROW CELLS (1984) (1)
Changes in purine salvage pathway enzyme activities during human lymphocyte differentiation induced by thymosin fraction 5. (1984) (1)
Workshop on perinatally acquired human immunodeficiency virus infection in long-term surviving children: a collaborative study of factors contributing to slow disease progression. The Long-Term Survivor Project. (1996) (1)
962 RESTORATION OF IN VITRO FUNCTION OF ADENOSINE DEAMINASE (ADA) DEFICIENT LYMPHOCYTES BY INTER-LEUKIN-2 (IL-2) (1985) (1)
Rejection of bone marrow transplant and resistance of alloantigen reactive cells to in vivo deoxyadenosine in adenosine deaminase deficiency. (1988) (1)
Saving lives globally: Dr. Krim and amfAR. (2006) (1)
Respiratory complications of ataxia-telangiectasia. (1969) (1)
Autoantibody, autoimmune disease, and immunodeficiency. (1977) (1)
Advances in HIV care and treatment in resource-poor countries (2009) (0)
Scientific, logistical, and ethical issues related to creation of a stem cell repository for use in experimental trials of gene therapy for AIDS. (1997) (0)
Immunopathogenesis of pediatric acquired immunodeficiency syndrome. (1988) (0)
Immunoglobulin E. (1970) (0)
"E-biomed" and clinical research. (1999) (0)
905 CHILDHOOD MIXED CONNECTIVE TISSUE DISEASE (1981) (0)
Immunologic responses in malnourished (1975) (0)
FORMULATION factor beta transforming growth that causes bone growth. (1994) (0)
Letter: Maternal-fetal graft vs host reaction. (1975) (0)
Selective IgA deficiency and autoimmunity. (1970) (0)
897 PNEUMOCOCCAL VACCINE (PnVx) IN SICKLE CELL DISEASE (SCD): IgG AND IgM ANTIBODY RESPONSE (1981) (0)
PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version (2002) (0)
FLUORESCENT PROTEIN TRACING—Fourth Edition (1977) (0)
Issues in bringing new drugs to the market. (2005) (0)
Infections after splenectomy. (1973) (0)
Pediatrics: AIDS in children. (1986) (0)
The preparation of medicaments for the treatment of infectious diseases (1987) (0)
Selective Absence of IgA (2007) (0)
RESTORATION OF IN VITRO FUNCTION OF ADENOSINE 41 DEAMINASE (ADA) DEFICIENT LYMPHOCYTES BY INTER-LEUKIN-2 (IL-2): 41 (1985) (0)
Pediatric AIDS. (2020) (0)
Introduction (2000) (0)
The Acquired Immunodeficiency Syndrome in Infants and Children (1986) (0)
Letter: Effect of thymosin on B-lymphocyte function. (1975) (0)
Immunologic hemophilia A abnormalities in patients with (1983) (0)
898 SUPPRESSOR/HELPER CELL FUNCTION IN CHILDREN WITH AUTOIMMUNE DISEASE (1981) (0)
Rationing of Antiretrovirals. A Step Backward. (2019) (0)
HIV tuberculosis and multidrug resistance: Implications for HIV-infected children. (2008) (0)
Disorders of the Immunological Mechanisms (1972) (0)
Letter: Rosette-forming cells. (1975) (0)
Placental-blood transplantation. (1997) (0)
FORMULATION DU FACTEUR DE CROISSANCE DE TRANSFORMATION BETA (TGF-β) PROVOQUANT LA CROISSANCE DES OS (1994) (0)
Adenosine deaminase and nucleoside phosphorylase in erythrocytes from marmosets (Saguinus sp). (1976) (0)
Human immunodeficiency virus infections in infants and children. (1988) (0)
TGF-beta composition to induce bone growth of (1994) (0)
Development of T-cell immunity in the fetus and infant. (1986) (0)

This paper list is powered by the following services:

Other Resources About Arthur J. Ammann

en.wikipedia.org

What Schools Are Affiliated With Arthur J. Ammann?

Arthur J. Ammann is affiliated with the following schools: